{"id":3636,"date":"2016-09-21T10:32:39","date_gmt":"2016-09-21T08:32:39","guid":{"rendered":"https:\/\/staging.blogs.yokogawa.de\/chemical-pharma\/unkategorisiert\/md-deutschland-verraet-3-themen-der-keynote\/"},"modified":"2022-07-04T06:53:49","modified_gmt":"2022-07-04T04:53:49","slug":"md-deutschland-verraet-3-themen-der-keynote","status":"publish","type":"post","link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/","title":{"rendered":"MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote"},"content":{"rendered":"<p>Andreas Helget, Managing Director der Yokogawa Deutschland, gibt erste Einblicke in die Thematik der Keynote auf der NAMUR-Hauptsitzung 2016. Herr Helget sagt, wie Yokogawa Deutschland seine &#8222;Gesch\u00e4ftsbasis&#8220; in Zukunft erweitern wird.<\/p>\n<p>Wollen Sie mehr wissen? Dann stellen Sie uns Ihre Fragen. Schreiben Sie uns in den Kommentaren.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Andreas Helget, Managing Director der Yokogawa Deutschland, gibt erste Einblicke in die Thematik der Keynote auf der NAMUR-Hauptsitzung 2016. Herr Helget sagt, wie Yokogawa Deutschland seine &#8222;Gesch\u00e4ftsbasis&#8220; in Zukunft erweitern wird. Wollen Sie mehr wissen? Dann stellen Sie uns Ihre [&hellip;]<\/p>\n","protected":false},"author":103,"featured_media":556,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[957,960,958,959],"tags":[],"coauthors":[79],"class_list":["post-3636","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-automation-de","category-corporate-de","category-optimization-de","category-services-de","author-helget"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote - Chemical Pharma Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote\" \/>\n<meta property=\"og:description\" content=\"Andreas Helget, Managing Director der Yokogawa Deutschland, gibt erste Einblicke in die Thematik der Keynote auf der NAMUR-Hauptsitzung 2016. Herr Helget sagt, wie Yokogawa Deutschland seine &#8222;Gesch\u00e4ftsbasis&#8220; in Zukunft erweitern wird. Wollen Sie mehr wissen? Dann stellen Sie uns Ihre [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemical Pharma Blog\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-21T08:32:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-04T04:53:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1579\" \/>\n\t<meta property=\"og:image:height\" content=\"887\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Andreas Helget\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/\"},\"author\":{\"name\":\"Andreas Helget\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#\\\/schema\\\/person\\\/c6c15133cc0485c7555f45ee42418525\"},\"headline\":\"MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote\",\"datePublished\":\"2016-09-21T08:32:39+00:00\",\"dateModified\":\"2022-07-04T04:53:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/\"},\"wordCount\":54,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/thumbnail_youtTube_Helget_Video.png\",\"articleSection\":[\"Automation\",\"Corporate\",\"Optimization\",\"Services\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/\",\"name\":\"MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote - Chemical Pharma Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/thumbnail_youtTube_Helget_Video.png\",\"datePublished\":\"2016-09-21T08:32:39+00:00\",\"dateModified\":\"2022-07-04T04:53:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/thumbnail_youtTube_Helget_Video.png\",\"contentUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/thumbnail_youtTube_Helget_Video.png\",\"width\":1579,\"height\":887},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/md-deutschland-verraet-3-themen-der-keynote\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/\",\"name\":\"Chemical Pharma Blog\",\"description\":\"Just another blogs.yokogawa.com Sites site\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#organization\",\"name\":\"Chemical Pharma Blog\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/05\\\/yokogawa-logo-e1651674418793.png\",\"contentUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/05\\\/yokogawa-logo-e1651674418793.png\",\"width\":302,\"height\":89,\"caption\":\"Chemical Pharma Blog\"},\"image\":{\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/#\\\/schema\\\/person\\\/c6c15133cc0485c7555f45ee42418525\",\"name\":\"Andreas Helget\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Helget_9399_250x250-150x150.jpgd11ce512bca58d005c116bcae861b383\",\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Helget_9399_250x250-150x150.jpg\",\"contentUrl\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/app\\\/uploads\\\/sites\\\/8\\\/2022\\\/06\\\/Helget_9399_250x250-150x150.jpg\",\"caption\":\"Andreas Helget\"},\"url\":\"https:\\\/\\\/www.yokogawa.com\\\/eu\\\/blog\\\/chemical-pharma\\\/de\\\/author\\\/helget\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote - Chemical Pharma Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/","og_locale":"de_DE","og_type":"article","og_title":"MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote","og_description":"Andreas Helget, Managing Director der Yokogawa Deutschland, gibt erste Einblicke in die Thematik der Keynote auf der NAMUR-Hauptsitzung 2016. Herr Helget sagt, wie Yokogawa Deutschland seine &#8222;Gesch\u00e4ftsbasis&#8220; in Zukunft erweitern wird. Wollen Sie mehr wissen? Dann stellen Sie uns Ihre [&hellip;]","og_url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/","og_site_name":"Chemical Pharma Blog","article_published_time":"2016-09-21T08:32:39+00:00","article_modified_time":"2022-07-04T04:53:49+00:00","og_image":[{"width":1579,"height":887,"url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png","type":"image\/png"}],"author":"Andreas Helget","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/#article","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/"},"author":{"name":"Andreas Helget","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/c6c15133cc0485c7555f45ee42418525"},"headline":"MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote","datePublished":"2016-09-21T08:32:39+00:00","dateModified":"2022-07-04T04:53:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/"},"wordCount":54,"commentCount":0,"publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/#primaryimage"},"thumbnailUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png","articleSection":["Automation","Corporate","Optimization","Services"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/","name":"MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote - Chemical Pharma Blog","isPartOf":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/#primaryimage"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/#primaryimage"},"thumbnailUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png","datePublished":"2016-09-21T08:32:39+00:00","dateModified":"2022-07-04T04:53:49+00:00","breadcrumb":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/#primaryimage","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png","width":1579,"height":887},{"@type":"BreadcrumbList","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/md-deutschland-verraet-3-themen-der-keynote\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/"},{"@type":"ListItem","position":2,"name":"MD Deutschland verr\u00e4t 3 Themen der NAMUR-Keynote"}]},{"@type":"WebSite","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#website","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/","name":"Chemical Pharma Blog","description":"Just another blogs.yokogawa.com Sites site","publisher":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#organization","name":"Chemical Pharma Blog","url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/05\/yokogawa-logo-e1651674418793.png","width":302,"height":89,"caption":"Chemical Pharma Blog"},"image":{"@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/#\/schema\/person\/c6c15133cc0485c7555f45ee42418525","name":"Andreas Helget","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpgd11ce512bca58d005c116bcae861b383","url":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpg","contentUrl":"https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/Helget_9399_250x250-150x150.jpg","caption":"Andreas Helget"},"url":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/helget\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png",1579,887,false],"thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-150x150.png",150,150,true],"medium":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-300x169.png",300,169,true],"medium_large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-768x431.png",768,431,true],"large":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-1024x575.png",1024,575,true],"1536x1536":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-1536x863.png",1536,863,true],"2048x2048":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video.png",1579,887,false],"post-thumbnail":["https:\/\/www.yokogawa.com\/eu\/blog\/app\/uploads\/sites\/8\/2022\/06\/thumbnail_youtTube_Helget_Video-356x200.png",356,200,true]},"uagb_author_info":{"display_name":"Andreas Helget","author_link":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/author\/helget\/"},"uagb_comment_info":0,"uagb_excerpt":"Andreas Helget, Managing Director der Yokogawa Deutschland, gibt erste Einblicke in die Thematik der Keynote auf der NAMUR-Hauptsitzung 2016. Herr Helget sagt, wie Yokogawa Deutschland seine &#8222;Gesch\u00e4ftsbasis&#8220; in Zukunft erweitern wird. Wollen Sie mehr wissen? Dann stellen Sie uns Ihre [&hellip;]","_links":{"self":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/3636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/users\/103"}],"replies":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/comments?post=3636"}],"version-history":[{"count":2,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/3636\/revisions"}],"predecessor-version":[{"id":11344,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/posts\/3636\/revisions\/11344"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/media\/556"}],"wp:attachment":[{"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/media?parent=3636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/categories?post=3636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/tags?post=3636"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.yokogawa.com\/eu\/blog\/chemical-pharma\/de\/wp-json\/wp\/v2\/coauthors?post=3636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}